| Ytd | 0.91% | |
| 1y | 68.04% |
| Open | 24.50 | Prev Close | 23.70 | Low | 22.57 | High | 24.75 | Mkt Cap | 42.36M |
| Vol | 156.89K | Avg Vol | 49.37K | EPS | -0.26 | P/E | -91.15 | Forward P/E | 13.34 |
| Beta | 1.27 | Short Ratio | 0.59 | Inst. Own | 8.79% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 24.29 | 200-d Avg | 24.23 | 1yr Est | 19.00 |
PRPO News
Precipio and NeoGenomics take different approaches to cancer diagnostics, but which oncology stock l
NEW HAVEN, Conn., June 12, 2026 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics compa
NEW HAVEN, Conn., June 11, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio,
PRPO's first-quarter 2026 sales are driven by pathology momentum, but CMS reimbursement cuts and hig
Precipio, Inc. (PRPO) Q1 2026 Earnings Call Transcript
Precipio (NASDAQ:PRPO) reported quarterly losses of $(0.81) per share. This is a 37.29 percent decre
Stable revenue performance driven by timing dynamics; expanding product pipeline expected to drive s
NEW HAVEN, Conn. , May 13, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, I
AI demand and pipeline growth headline top Zacks stock reports on NVIDIA, Mastercard and AbbVie.
NEW HAVEN, Conn. , May 06, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, I
Precipio, Inc. (PRPO) Q4 2025 Earnings Call Prepared Remarks Transcript
Precipio (NASDAQ: PRPO - Get Free Report) and Healthcare Triangle (NASDAQ: HCTI - Get Free Report) a
NEW HAVEN, Conn., March 12, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio,
Precipio (NASDAQ: PRPO - Get Free Report) and Zhongchao (NASDAQ: ZCMD - Get Free Report) are both sm
Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces some preliminary (unaud
In Q4-2025 the Company generated ~$400K in Operating Cash Flow, and Adjusted EBITDA of close to $1M
Precipio, Inc. (NASDAQ: PRPO - Get Free Report) saw a large growth in short interest in January. As
Precipio, Inc. (NASDAQ: PRPO - Get Free Report) shares crossed below its 200-day moving average duri
Precipio (NASDAQ: PRPO - Get Free Report) and SOPHiA GENETICS (NASDAQ: SOPH - Get Free Report) are b
Precipio, Inc. (NASDAQ: PRPO - Get Free Report) was the target of a significant increase in short in
During the session on Thursday, 461 stocks hit new 52-week lows.
On Friday, 1043 companies hit new 52-week lows.
On Friday, 431 companies hit new 52-week lows.
Before 10 a.m. ET on Tuesday, 166 companies hit new 52-week highs.
Stocks That Hit 52-Week Lows On Thursday
Stocks Which Set New 52-Week Low Yesterday, October 10th